Nova Eye EBITDA vs. Book Value Per Share
| EYE Stock | 0.15 0.01 6.25% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -6 M | Current Value -5.7 M | Quarterly Volatility 5.9 M |
For Nova Eye profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nova Eye to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nova Eye Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nova Eye's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nova Eye Medical over time as well as its relative position and ranking within its peers.
Nova |
Nova Eye Medical Book Value Per Share vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nova Eye's current stock value. Our valuation model uses many indicators to compare Nova Eye value to that of its competitors to determine the firm's financial worth. Nova Eye Medical is rated # 5 in ebitda category among its peers. It also is rated # 5 in book value per share category among its peers . At this time, Nova Eye's EBITDA is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Eye's earnings, one of the primary drivers of an investment's value.Nova Book Value Per Share vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Nova Eye |
| = | (5.98 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Nova Eye |
| = | 0.09 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Nova Book Value Per Share Comparison
Nova Eye is rated # 4 in book value per share category among its peers.
Nova Eye Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nova Eye, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nova Eye will eventually generate negative long term returns. The profitability progress is the general direction of Nova Eye's change in net profit over the period of time. It can combine multiple indicators of Nova Eye, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -693 K | -658.4 K | |
| Operating Income | -3.8 M | -3.6 M | |
| Income Before Tax | -8.8 M | -8.4 M | |
| Total Other Income Expense Net | -5 M | -4.7 M | |
| Income Tax Expense | -5.2 M | -4.9 M | |
| Net Loss | -8.8 M | -8.4 M | |
| Interest Income | 124 K | 179 K | |
| Net Loss | -13.8 M | -13.1 M | |
| Net Interest Income | 54 K | 56.7 K | |
| Net Loss | -8.8 M | -9.2 M | |
| Change To Netincome | 5.4 M | 5.7 M |
Nova Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nova Eye. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nova Eye position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nova Eye's important profitability drivers and their relationship over time.
Use Nova Eye in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nova Eye position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nova Eye will appreciate offsetting losses from the drop in the long position's value.Nova Eye Pair Trading
Nova Eye Medical Pair Trading Analysis
The ability to find closely correlated positions to Nova Eye could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nova Eye when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nova Eye - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nova Eye Medical to buy it.
The correlation of Nova Eye is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nova Eye moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nova Eye Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nova Eye can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nova Eye position
In addition to having Nova Eye in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Most Shorted Equities Thematic Idea Now
Most Shorted Equities
Dynamically calculated list of top equities currently trending upward via a buy-out by investors. The Most Shorted Equities theme has 220 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Most Shorted Equities Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.